Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has shared an announcement.
Clarity Pharmaceuticals Ltd. has announced that State Street Corporation and its subsidiaries have ceased to be substantial holders in the company as of May 13, 2025. This change in substantial holding could impact the company’s shareholder structure and influence its market perception, potentially affecting investor confidence and stakeholder interests.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$6.10 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 2,690,964
Technical Sentiment Signal: Sell
Current Market Cap: A$822.7M
For an in-depth examination of CU6 stock, go to TipRanks’ Stock Analysis page.